<DOC>
	<DOCNO>NCT02965898</DOCNO>
	<brief_summary>Acute pancreatitis ( AP ) may develop chronic pancreatitis ( CP ) . In Finland , ethiology alcohol 80 % case . Several symptom low quality life CP patient , include abdominal pain , exocrine endocrine pancreatic insufficiency . Recently , investigator others find vitamin D may protect formation fibrosis cellular level . The investigator hypothesize first AP may able protect formation fibrosis lead CP Vitamin D , design RCT . The aim study whether investigator prevent CP vitamin D substitute . In randomized control patient study , patient first AP randomize either normal recommend ( 10 μ ) large safe dose ( 100 μg ) . vitamin D substitute daily . The patient examine MRI/MRCP image laboratory test baseline recovery AP yearly . Primary endpoint development parenchymal change possibly related fibrosis . Secondary endpoint development CP Mannheim criterion , CP relate complication mortality . The first analysis do 3 year . The enrollment begin 26.9.2016</brief_summary>
	<brief_title>The Effect Vitamin D Substitution Development Chronic Pancreatitis</brief_title>
	<detailed_description />
	<mesh_term>Pancreatitis</mesh_term>
	<mesh_term>Pancreatitis , Chronic</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>First alcohol induce acute pancreatitis Willing participate 3 year RCT Renal failure Hypercalcemia High serum level vitamin D Unwilling participate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>101 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>chronic pancreatitis</keyword>
	<keyword>vitamin</keyword>
	<keyword>pancreatitis</keyword>
	<keyword>Pancreatic stellate cell</keyword>
	<keyword>rct</keyword>
</DOC>